FLT4 and cancer: In PCa, antagonizing VEGFR-3 has been reported to be an effective form of anticancer therapy, as suggested by results showing that a specific VEGFR-3 antagonist successfully inhibits lymphangiogenesis and cancer metastasis in PCa-bearing mice [86].